Tumor cell stemness is usually manifested by the upregulation of OCT4, CD133, and CD44, which were identified as key factors in maintaining stem cell properties, such as self-renewal, tumorigenesis, and drug resistance (Walcher et al., 2020; Zhou et al., 2023). The gene discussed is PROM1; the disease is neoplasm.